has been cited by the following article(s):
|
[1]
|
Is It Time to Reconsider the Clinical Role of ErbB Targeted Therapy in Endometrial Cancer?
|
|
2022 |
|
|
|
|
[2]
|
Systems for the delivery of chemotherapeutic drugs, new approaches and perspective
|
|
Russian Open Medical Journal,
2017 |
|
|
|
|
[3]
|
Endometrial Cancer Treatment: New Insights into the Role of Erbb Receptors
|
|
2016 |
|
|
|
|
[4]
|
Endometrial cancer treatment: ne w insights into the role of erbb receptors
|
|
2016 |
|
|
|
|
[5]
|
New insights in endometrial cancer treatment
|
|
2016 |
|
|
|
|
[6]
|
Standard and novel therapies in endometrial cancer
|
|
2016 |
|
|
|
|
[7]
|
ErbB targeted therapy in endometrial cancer
|
|
Int J Clin Ther Diagn. S,
2015 |
|
|
|
|
[8]
|
Endometrial Cancer-Diagnosis
|
|
Int J Clin Ther Diagn. S,
2015 |
|
|
|
|
[9]
|
Present and Future in Endometrial Cancer Treatment
|
|
Obstet Gynecol Int J,
2015 |
|
|
|
|
[10]
|
Current Treatment Approach of Endometrial Cancer
|
|
Int J Clin Ther Diagn. S,
2015 |
|
|
|
|
[11]
|
Molecular Mechanisms, Expression and Clinical Role of Erbb Re-ceptors in Endometrial Cancer
|
|
Int J Clin Ther Diagn. S,
2015 |
|
|
|
|
[12]
|
Molecular biology, expression and clinical significance of ErbB receptors in endometrial cancer
|
|
HJOG,
2014 |
|
|
|
|
[1]
|
Present and Future in Endometrial Cancer Treatment
Obstetrics & Gynecology International Journal,
2015
DOI:10.15406/ogij.2015.02.00031
|
|
|
|